Skip to main content

Table 1 Cases reported in literature presenting with eye movement disorders in the setting of calcineurin inhibitor therapy

From: Isolated diplopia associated with calcineurin inhibitor therapy in a patient with idiopathic membranous nephropathy: a case report

Study Title and author

Age/Sex

Diagnosis

Drug name

Days after treatment

Route of administration

Drug level

Neurological Deficit

Openshaw, Slatkin et al. 1997 [4]

 

Post bone marrow transplant for Acute Lymphocytic Leukemia

Cyclosporin

72

Per Oral

475 ng/ml

Unilateral six nerve palsy

 Case 1

16/Female

 Case 2

37/Female

Post bone marrow transplant for Acute Lymphocytic Leukemia

Cyclosporin

73

Per Oral

1356 ng/ml

Ptosis, bilateral sixth nerve palsy

 Case 3

18/Female

Acute Leukemia Mixed lineage

Cyclosporin

47

Intravenous

700 ng/ml

Ptosis, bilateral sixth nerve palsy encephalopathy

 Case 4

20/Female

Chronic Myelogenous Leukemia

Cyclosporin

80

Intravenous

Not Reported

Ptosis, bilateral sixth nerve palsy encephalopathy seizure

Lai, Kerrison et al. 2004 [2]

50/Male

Post orthotopic cardiac transplant

FK506

93

Intravenous

10–20 ng/dl

Worsening headache horizontal diplopia, Bilateral Inter nuclear opthalmoplegia

Oliverio, Restrepo et al. 2000 [3]

30/female

Post bone marrow transplant for chronic myeloid leukemia

FK506

84

Per Oral

Reported as within therapeutic range

Diplopia, horizontal nystagmus, and bilateral sixth nerve palsy. visual hallucinations